# Midland States Bancorp, Inc.: financial statements, quarterly

MSBI · Nasdaq · CIK 1466026 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/msbi.md) · [Financials](/companies/msbi/financials.md) · [Filings](/companies/msbi/filings.md) · [Insiders](/companies/msbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [46.6 d](/filings/0001466026-24-000009.md) | [45.8](/filings/0001466026-24-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.1 d](/filings/0001466026-26-000020.md) | [6.4](/filings/0001466026-25-000031.md) | [6.1](/filings/0001466026-25-000038.md) | [4.5](/filings/0001466026-25-000070.md) | [(8.2) d](/filings/0001466026-26-000020.md) | [3.2](/filings/0001466026-26-000049.md) | [2.8](/filings/0001466026-26-000078.md) | [3.8](/filings/0001466026-26-000099.md) | [(0.4) d](/filings/0001466026-26-000020.md) | [5.6](/filings/0001466026-26-000049.md) | [5.9](/filings/0001466026-26-000078.md) | [6.6](/filings/0001466026-26-000099.md) |
| Net income | $m | [20.1 d](/filings/0001466026-26-000020.md) | [22.7](/filings/0001466026-25-000031.md) | [25.7](/filings/0001466026-25-000038.md) | [20.4](/filings/0001466026-25-000070.md) | [(30.8) d](/filings/0001466026-26-000020.md) | [(141)](/filings/0001466026-26-000049.md) | [12.0](/filings/0001466026-26-000078.md) | [7.6](/filings/0001466026-26-000099.md) | [(2.9) d](/filings/0001466026-26-000020.md) | [18.5](/filings/0001466026-26-000049.md) | [19.9](/filings/0001466026-26-000078.md) | [22.8](/filings/0001466026-26-000099.md) |
| Diluted EPS | $ per share | not reported | [0.92](/filings/0001466026-25-000031.md) | [1.06](/filings/0001466026-25-000038.md) | [0.83](/filings/0001466026-25-000070.md) | not reported | [(6.58)](/filings/0001466026-26-000049.md) | [0.44](/filings/0001466026-26-000078.md) | [0.24](/filings/0001466026-26-000099.md) | not reported | [0.74](/filings/0001466026-26-000049.md) | [0.82](/filings/0001466026-26-000078.md) | [0.95](/filings/0001466026-26-000099.md) |
| Basic EPS | $ per share | not reported | [0.92](/filings/0001466026-25-000031.md) | [1.06](/filings/0001466026-25-000038.md) | [0.83](/filings/0001466026-25-000070.md) | not reported | [(6.58)](/filings/0001466026-26-000049.md) | [0.44](/filings/0001466026-26-000078.md) | [0.24](/filings/0001466026-26-000099.md) | not reported | [0.74](/filings/0001466026-26-000049.md) | [0.82](/filings/0001466026-26-000078.md) | [0.95](/filings/0001466026-26-000099.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [135](/filings/0001466026-25-000021.md) | [167](/filings/0001466026-24-000018.md) | [125](/filings/0001466026-24-000035.md) | [122](/filings/0001466026-24-000041.md) | [115](/filings/0001466026-26-000020.md) | [102](/filings/0001466026-25-000031.md) | [177](/filings/0001466026-25-000038.md) | [166](/filings/0001466026-25-000070.md) | [128](/filings/0001466026-26-000099.md) | [114](/filings/0001466026-26-000049.md) | [299](/filings/0001466026-26-000078.md) | [99.6](/filings/0001466026-26-000099.md) |
| Total assets | $m | [7,790](/filings/0001466026-26-000020.md) | [7,764](/filings/0001466026-25-000031.md) | [7,708](/filings/0001466026-25-000038.md) | [7,704](/filings/0001466026-25-000070.md) | [7,507](/filings/0001466026-26-000020.md) | [7,285](/filings/0001466026-26-000049.md) | [7,108](/filings/0001466026-26-000078.md) | [6,912](/filings/0001466026-26-000099.md) | [6,513](/filings/0001466026-26-000099.md) | [6,548](/filings/0001466026-26-000049.md) | [6,701](/filings/0001466026-26-000078.md) | [6,817](/filings/0001466026-26-000099.md) |
| Total liabilities | $m | [7,075](/filings/0001466026-25-000021.md) | [7,041](/filings/0001466026-25-000021.md) | [6,971](/filings/0001466026-25-000021.md) | [6,933](/filings/0001466026-25-000021.md) | [6,796](/filings/0001466026-26-000020.md) | [6,713](/filings/0001466026-25-000031.md) | [6,534](/filings/0001466026-25-000038.md) | [6,328](/filings/0001466026-25-000070.md) | [5,948](/filings/0001466026-26-000099.md) | [5,989](/filings/0001466026-26-000049.md) | [6,131](/filings/0001466026-26-000078.md) | [6,285](/filings/0001466026-26-000099.md) |
| Short-term borrowings | $m | [34.9](/filings/0001466026-25-000021.md) | [214](/filings/0001466026-24-000018.md) | [7.2](/filings/0001466026-24-000035.md) | [13.8](/filings/0001466026-24-000041.md) | [87.5](/filings/0001466026-26-000020.md) | [40.2](/filings/0001466026-25-000031.md) | [8.7](/filings/0001466026-25-000038.md) | [147](/filings/0001466026-25-000070.md) | [60.2](/filings/0001466026-26-000099.md) | [153](/filings/0001466026-26-000049.md) | [7.6](/filings/0001466026-26-000078.md) | [151](/filings/0001466026-26-000099.md) |
| Shareholders' equity | $m | [715](/filings/0001466026-26-000020.md) | [723](/filings/0001466026-25-000038.md) | [737](/filings/0001466026-25-000070.md) | [771](/filings/0001466026-25-000070.md) | [711](/filings/0001466026-26-000099.md) | [571](/filings/0001466026-26-000078.md) | [574](/filings/0001466026-26-000099.md) | [584](/filings/0001466026-26-000099.md) | [565](/filings/0001466026-26-000099.md) | [559](/filings/0001466026-26-000078.md) | [570](/filings/0001466026-26-000099.md) | [531](/filings/0001466026-26-000099.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [55.9 d](/filings/0001466026-26-000020.md) | [43.1](/filings/0001466026-25-000031.md) | [31.4 d](/filings/0001466026-25-000038.md) | [46.5 d](/filings/0001466026-25-000070.md) | [55.5 d](/filings/0001466026-26-000020.md) | [24.7](/filings/0001466026-26-000049.md) | [28.1 d](/filings/0001466026-26-000078.md) | [80.0 d](/filings/0001466026-26-000099.md) | [(7.1) d](/filings/0001466026-26-000020.md) | [17.0](/filings/0001466026-26-000049.md) | [29.5 d](/filings/0001466026-26-000078.md) | [38.4 d](/filings/0001466026-26-000099.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001466026-26-000020.md) | [0.5](/filings/0001466026-25-000031.md) | [1.6 d](/filings/0001466026-25-000038.md) | [2.1 d](/filings/0001466026-25-000070.md) | [2.7 d](/filings/0001466026-26-000020.md) | [1.8](/filings/0001466026-26-000049.md) | [1.4 d](/filings/0001466026-26-000078.md) | [1.4 d](/filings/0001466026-26-000099.md) | [0.7 d](/filings/0001466026-26-000020.md) | [0.6](/filings/0001466026-26-000049.md) | [0.3 d](/filings/0001466026-26-000078.md) | [0.5 d](/filings/0001466026-26-000099.md) |
| Dividends paid | $m | [6.6 d](/filings/0001466026-26-000020.md) | [6.8](/filings/0001466026-25-000031.md) | [6.8 d](/filings/0001466026-25-000038.md) | [6.7 d](/filings/0001466026-25-000070.md) | [6.8 d](/filings/0001466026-26-000020.md) | [6.8](/filings/0001466026-26-000049.md) | [6.8 d](/filings/0001466026-26-000078.md) | [7.0 d](/filings/0001466026-26-000099.md) | [7.1 d](/filings/0001466026-26-000020.md) | [6.9](/filings/0001466026-26-000049.md) | [6.8 d](/filings/0001466026-26-000078.md) | [7.0 d](/filings/0001466026-26-000099.md) |
| Share repurchases | $m | [2.9 d](/filings/0001466026-26-000020.md) | [1.9](/filings/0001466026-25-000031.md) | [3.0 d](/filings/0001466026-25-000038.md) | [0.5 d](/filings/0001466026-25-000070.md) | [(0.0) d](/filings/0001466026-26-000020.md) | [0.0](/filings/0001466026-26-000049.md) | [0.0 d](/filings/0001466026-26-000078.md) | [0.0 d](/filings/0001466026-26-000099.md) | [9.7 d](/filings/0001466026-26-000020.md) | [7.9](/filings/0001466026-26-000049.md) | [2.7 d](/filings/0001466026-26-000078.md) | [(0.0) d](/filings/0001466026-26-000099.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.5](/filings/0001466026-24-000018.md) | [22.2](/filings/0001466026-24-000035.md) | [22.0](/filings/0001466026-24-000041.md) | [21.8](/filings/0001466026-25-000031.md) | [21.7](/filings/0001466026-25-000038.md) | [21.7](/filings/0001466026-25-000070.md) | [21.8](/filings/0001466026-26-000049.md) | [21.8](/filings/0001466026-26-000078.md) | [21.9](/filings/0001466026-26-000099.md) | [21.3](/filings/0001466026-26-000049.md) | [21.1](/filings/0001466026-26-000078.md) | [21.1](/filings/0001466026-26-000099.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,802,347 at 2026-10-20, from the cover of the [10-Q filed 2026-10-29](/filings/0001466026-26-000099.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:29 ET. No prices; not investment advice.